Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06721351
NA

Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence

Sponsor: Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health

View on ClinicalTrials.gov

Summary

This research study is being conducted to improve eye care by using artificial intelligence (AI) to make diabetic eye screenings faster and more accessible. AI technology mimics human decision-making, enabling computers and systems to analyze medication information. Specifically for this screening, AI examines digital images of the eye and based on that information, may identify if a participant has diabetic retinopathy. It can assist doctors in making decisions about a participant's diagnosis, treatment or care plans to improve patient care. This is a collaboration between San Ysidro Health (SYHealth), University of California, San Diego (UC San Diego), and Eyenuk. The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) awarded SYHealth funds to demonstrate the value of AI technologies in diverse, real-world settings.

Official title: Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence -DRES-POCAI: AI - Clinical Intervention at San Ysidro Health

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

548

Start Date

2024-07-27

Completion Date

2026-04-30

Last Updated

2025-11-06

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Diabetic Retinopathy screening Point of Care Artificial Intelligence

Random assignment of participants to intervention and control groups minimizes confounding variables. This ensures that any observed differences in outcomes are likely due to the intervention itself and not pre-existing differences between the groups. Participants of the DRES-POCAI study will be randomized into two groups: usual care (receive a retinal screening by an optometrist) or intervention group (receive a retinal screening using a special camera and EyeArt® system, an autonomous AI-based DR screening). The randomization will occur after consenting and completing the surveys, prior to conducting the DR screening process (for those randomized to the intervention group).

Locations (3)

San Ysidro Health Chula Vista

Chula Vista, California, United States

San Ysidro Health - Comprehensive Health Center - Ocean View

San Diego, California, United States

San Ysidro Health King-Chavez Health Center

San Diego, California, United States